IFNG and neoplasm: Pegilodecakin is a long-acting, PEGylated version of IL-10 which was found to induce the expression of IFN-γ and granzymes in tumor-infiltrating CD8+ T cells, thereby increasing the number and enhancing the activities of CD8 + T cells.